Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 7/7/20 → 7/7/23 |
Funding
- PPD Investigator Services, LLC (Prot #RMC-4630-02)
- Revolution Medicines, Inc. (Prot #RMC-4630-02)
Prot #RMC-4630-02: A Phase 1b/2, Open-Label, Multicenter Dose-Escalation and Dose-Expansion Study of the Combination of RMC-4630 with Cobimetinib in Adult Participants with Relapsed/Refractory Solid Tumors and a Phase 1b Study of RMC-4630 with Osimertinib
- Chae, Young Kwang (PD/PI)
Project: Research project